Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia.

July 11, 2017 at 4:06 pm

Tex Heart Inst J. Feb 1, 2017 V.44 N.1 P.10-15.

Salvador VB, Chapagain B, Joshi A, Brennessel DJ.

Abstract

Crucial to the management of staphylococcal bacteremia is an accurate evaluation of associated endocarditis, which has both therapeutic and prognostic implications. Because the clinical presentation of endocarditis can be nonspecific, the judicious use of echocardiography is important in distinguishing patients at high risk of developing endocarditis.

In the presence of high-risk clinical features, an early transesophageal echocardiogram is warranted without prior transthoracic echocardiography.

The purpose of this study was to investigate the clinical risk factors for staphylococcal infective endocarditis that might warrant earlier transesophageal echocardiography and to describe the incidence of endocarditis in cases of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia.

A retrospective case-control study was conducted by means of chart review of 91 patients consecutively admitted to a community hospital from January 2009 through January 2013. Clinical risk factors of patients with staphylococcal bacteremia were compared with risk factors of patients who had definite diagnoses of infective endocarditis.

There were 69 patients with bacteremia alone (76%) and 22 patients with endocarditis (24%), as verified by echocardiography. Univariate analysis showed that diabetes mellitus (P=0.024), the presence of an automatic implantable cardioverter-defibrillator/pacemaker (P=0.006) or a prosthetic heart valve (P=0.003), and recent hospitalization (P=0.048) were significantly associated with developing infective endocarditis in patients with S. aureus bacteremia.

The incidence of methicillin-resistant and methicillin-sensitive S. aureus bacteremia was similar in the bacteremia and infective-endocarditis groups (P=0.437).

In conclusion, identified high-risk clinical factors in the presence of bacteremia can suggest infective endocarditis.

Early evaluation with transesophageal echocardiography might well be warranted.

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317353/pdf/i1526-6702-44-1-10.pdf

Advertisements

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Epidemiología, F.O.D, Infecciones cardio-vasculares, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update.

Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens. Surveillance and outbreak report LEGIONNAIRES’ DISEASE IN EUROPE, 2011 TO 2015


Calendar

July 2017
M T W T F S S
« Jun   Aug »
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Most Recent Posts


%d bloggers like this: